FDA approves first glucose sensing tech that doesn’t require routine finger sticks

Abbott (NYSE:ABT) said yesterday that the FDA approved its FreeStyle Libre Flash glucose monitoring system as a replacement for blood glucose monitoring for adults with diabetes.

The company’s technology doesn’t require finger stick calibration and eliminates the need for users to routinely stick their fingers for samples.

Get the full story at our sister site, Drug Delivery Business News.

The post FDA approves first glucose sensing tech that doesn’t require routine finger sticks appeared first on MassDevice.

from MassDevice http://ift.tt/2yuCu3H